Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Inmune Bio (NASDAQ: INMB) Director Receives 100,000 Derivative Securities

Inmune Bio, Inc. (NASDAQ: INMB), a biotechnology company, awarded director Clark Ronnie Duane 100,000 derivative securities on September 15, 2026. Clark’s post-transaction holding was 100,000 derivative securities in Inmune Bio. The award itself accounted for 100.0% of that resulting total. Clark reported a new …

Vinay Lochav | 23 September 2026

Inmune Bio (NASDAQ: INMB) Names Clark Ronnie Duane as Insider

Inmune Bio, Inc. (NASDAQ: INMB) is a biotechnology company. The record also identifies him as a director of Inmune Bio.

Vinay Lochav | 23 September 2026

IONIS Pharmaceuticals Inc. (NASDAQ: IONS) Reports Positive Sefaxersen Phase 3 Results

Ionis Pharmaceuticals and Roche reported positive interim Phase 3 results for sefaxersen, which met its primary endpoint by improving proteinuria versus placebo. IgA nephropathy can lead to end-stage kidney disease in up to 50% of patients, and the study will continue measuring kidney function.Key …

Vinay Lochav | 23 September 2026

Armata Pharmaceuticals (AMEX: ARMP) Adds $3.7M for AP-SA02 Phase 3

Armata Pharmaceuticals received an additional $3.7 million in non-dilutive Department of War funding for AP-SA02’s Phase 3 development. The money matters to investors because it is the program’s first Phase 3-specific support and lifts cumulative non-dilutive funding under the award to approximately $32.4 million.Key …

Vinay Lochav | 23 September 2026

BioCardia (NASDAQ: BCDA) Sets 2026 FDA and Japan Regulatory Milestones

BioCardia, Inc. (NASDAQ: BCDA) is a biotechnology company advancing regulatory milestones for its cardiovascular therapies and delivery technology. The company is targeting a CardiAMP HF submission in Japan during 2026 and plans to move its Helix program into another FDA review step during the …

Vinay Lochav | 23 September 2026

Pearson PLC (NYSE: PSO) Adds Three Directors to Board

Pearson PLC (NYSE: PSO), a publishing company focused on books and magazines, is appointing three directors to its board. Michael Barkin and Vivek Sharma will join as independent Non-Executive Directors, while Alex Svensson will become a Non-Executive Director. All three appointments take effect on …

Vinay Lochav | 23 September 2026

Terra Innovatum Global (NASDAQ: NKLR) Adds Three Independent Directors

Its board composition changed on September 17 and September 22, 2026, with three directors departing or moving into a different role and three new independent directors appointed.

Vinay Lochav | 23 September 2026

Terra Innovatum Global N.V. (NASDAQ: NKLR) Adds Three Independent Directors

Terra Innovatum Global N.V. (NASDAQ: NKLR) is an electrical products company. Three independent directors joined its board on September 22, following the resignations of two directors and Peter Hastings’ move into a consulting role on September 17.

Vinay Lochav | 23 September 2026

AC Immune SA (NASDAQ: ACIU) Reports 100% ACI-7104 Response in Parkinson’s Trial

All primary endpoints were met, and the treatment was generally safe and well tolerated. The data also showed a 100% response rate after three immunizations, supporting the program’s move toward its next development stage. The trial is randomized, double-blind and placebo-controlled.

Vinay Lochav | 23 September 2026

Anteris Technologies (NASDAQ: AVR) Extends Harvey Supply Agreement Through December 31

Its supply and quality arrangement with Harvey Industries Group Pty Ltd now has a further term that can run through December 31, 2026, subject to an earlier replacement agreement.

Vinay Lochav | 23 September 2026
Support

Hi! How can we help you today?

Loading…